TSS
PBYI icon

Two Sigma Securities’s Puma Biotechnology PBYI Stock Holding History

Two Sigma Securities’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-12,173
Closed -$31K – 2799
2024
Q3 		$31K Buy
+12,173
New +$36.8K ﹤0.01% 2429
2022
Q3 		– Sell
-14,156
Closed -$40K – 2967
2022
Q2 		$40K Buy
+14,156
New +$35.2K ﹤0.01% 1873
2019
Q4 		– Sell
-10,396
Closed -$112K – 2571
2019
Q3 		$112K Buy
+10,396
New +$112K ﹤0.01% 1935
2019
Q2 		– Sell
-5,263
Closed -$204K – 2339
2019
Q1 		$204K Buy
+5,263
New +$161K ﹤0.01% 1476
2017
Q3 		– Sell
-3,207
Closed -$280K – 1147
2017
Q2 		$280K Buy
+3,207
New +$179K 0.05% 385

Other funds holding PBYI

ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Two Sigma Securities's PBYI Position: Q4 2024 in Review

Two Sigma Securities sold out of Puma Biotechnology (PBYI) in Q4 2024, closing a stake of 12,173 shares — an estimated $31K sold.

Two Sigma Securities first reported a position in PBYI in Q2 2017 and held it in 5 quarters. The position peaked at $280K in Q2 2017. 112 funds tracked by Wall St. Rank hold PBYI as of Q4 2024.

  • Two Sigma Securities reported no remaining Puma Biotechnology position as of Q4 2024 after selling out during the quarter.
  • Two Sigma Securities sold 12,173 Puma Biotechnology shares in Q4 2024, an estimated $31K.
  • Two Sigma Securities first reported a position in Puma Biotechnology in Q2 2017 and held it in 5 quarters.
  • Two Sigma Securities's Puma Biotechnology position peaked at $280K in Q2 2017.
  • 112 funds tracked by Wall St. Rank held Puma Biotechnology as of Q4 2024.

Based on Two Sigma Securities's 13F filing for Q4 2024, filed 14 Feb 2025.